氨酸在短期的床上休息期间调节胰岛素抵抗
Alja Ivetac1, Teresa Cannito1, Alessio Nunnari1
1Department of Medical, Surgical and Health Sciences, Cattinara Hospital, University of Trieste, Trieste, Italy.
Nutrition (Burbank, Los Angeles County, Calif.)
|February 24, 2026
概括
在不活动期间保持血清水平可能会防止胰岛素抵抗 (IR). 这项研究发现,血清素会影响IR,但IR不会影响血清素水平,这表明血清素有保护作用.
科学领域:
- 运动生理学 运动生理学
- 代谢健康 代谢健康
- 营养生物化学 营养生物化学
背景情况:
- 不活动期间的肌肉卸载与胰岛素抵抗 (IR) 和氨基酸 (AA) 轮的改变有关.
- 在不活动期间研究AAs在IR中的作用对于理解代谢变化至关重要.
研究的目的:
- 评估氨基酸 (AAs) 在不活动期间对胰岛素抵抗 (IR) 的潜在影响.
- 为了确定特定的AA档案和IR标记之间的关系.
主要方法:
- 来自三项卧床休息研究的血AA,葡萄糖和胰岛素的回顾性分析.
- 使用多变量归算缺失的AA值来评估9天不活动期间与HOMA IR相关的趋势.
- 通用线性混合模型 (GLMM) 适用于检查选定的AA对HOMA IR的影响.
主要成果:
- 赛林在HOMA IR上表现出显著的负定效应,表明它具有保护作用.
- 观察到一种单向关系,血清素对HOMA IR产生影响,而不是相反.
- 血清水平在床上休息时波动,血清可用性的下降与HOMA IR的上升相关.
结论:
- 在不活动期间,血清素水平似乎对胰岛素抵抗 (IR) 有反向影响.
- 在短期的床上休息期间保持足够的血清水平可能会起到保护性作用,防止IR的发展.
- 需要进一步研究血清素补充剂或在不活动期间维持血清素水平的策略.
相关概念视频
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.8K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.8K
Insulin: Dosing Regimen and Adverse Effects
935
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
935
Insulin: The Receptor and Signaling Pathways
4.7K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
4.7K
Hormones Regulating Blood Glucose
7.4K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
7.4K
Cell Specific Gene Expression
16.7K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.7K
Dipeptidyl Peptidase 4 Inhibitors
780
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
780


